{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:50:57Z","timestamp":1791924657933,"version":"4.3.4"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["\u7f16\u53f781603410"],"award-info":[{"award-number":["\u7f16\u53f781603410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["No. 2016102A"],"award-info":[{"award-number":["No. 2016102A"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["\uff08\u7f16\u53f72016208A"],"award-info":[{"award-number":["\uff08\u7f16\u53f72016208A"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["\uff08\u7b2c18TS086\u53f7"],"award-info":[{"award-number":["\uff08\u7b2c18TS086\u53f7"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.01393","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T04:54:56Z","timestamp":1578977696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0041-0101(01)00191-x","article-title":"Cytolytic peptide and protein toxins from sea anemones (Anthozoa: Actiniaria).","volume":"40","author":"Anderluh","year":"2002","journal-title":"Toxicon"},{"key":"B2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0304-4165(93)90082-j","article-title":"A potassium channel toxin from the secretion of the sea anemone Bunodosoma granulifera. Isolation, amino acid sequence and biological activity.","volume":"1157","author":"Aneiros","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.jid.5700717","article-title":"Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.","volume":"127","author":"Azam","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.toxicon.2014.05.002","article-title":"Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.","volume":"87","author":"Bartok","year":"2014","journal-title":"Toxicon"},{"key":"B5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/1073858405278016","article-title":"Potassium channels, memory T cells, and multiple sclerosis.","volume":"11","author":"Beeton","year":"2005","journal-title":"Neuroscientist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/187152811797200641","article-title":"Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.","volume":"10","author":"Beeton","year":"2011","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ana.21007","article-title":"Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy.","volume":"60","author":"Beraud","year":"2006","journal-title":"Ann. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2015.04.004","article-title":"Molecular dynamics of Kv1.3 ion channel and structural basis of its inhibition by scorpion toxin-OSK1 derivatives.","author":"Bhuyan","year":"2015","journal-title":"Biophys. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11064-018-2509-8","article-title":"Voltage gated potassium channel Kv1.3 is upregulated on activated astrocytes in experimental autoimmune encephalomyelitis.","volume":"43","author":"Bozic","year":"2018","journal-title":"Neurochem. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.22443","article-title":"The astrocyte in multiple sclerosis revisited.","volume":"61","author":"Brosnan","year":"2013","journal-title":"Glia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","article-title":"Focused ultrasound-mediated drug delivery through the blood-brain barrier.","volume":"15","author":"Burgess","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0041-0101(95)00013-c","article-title":"Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus.","volume":"33","author":"Castaneda","year":"1995","journal-title":"Toxicon"},{"key":"B16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1084\/jem.160.2.369","article-title":"Voltage-gated potassium channels are required for human T lymphocyte activation.","volume":"160","author":"Chandy","year":"1984","journal-title":"J. Exp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","article-title":"Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease.","volume":"38","author":"Chandy","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"45079","DOI":"10.1074\/jbc.M106182200","article-title":"Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus.","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/acn3.513","article-title":"Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.","volume":"5","author":"Chen","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1096\/fj.14-251967","article-title":"Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases.","volume":"28","author":"Chhabra","year":"2014","journal-title":"FASEB J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.toxicon.2011.07.016","article-title":"Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.","volume":"59","author":"Chi","year":"2012","journal-title":"Toxicon"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14644","article-title":"Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions.","volume":"8","author":"Chiang","year":"2017","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1432-1033.1997.00192.x","article-title":"A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity.","volume":"244","author":"Cotton","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1682\/jrrd.2004.08.0111","article-title":"Oligodendrocyte cell death in pathogenesis of multiple sclerosis: protection of oligodendrocytes from apoptosis by complement.","volume":"43","author":"Cudrici","year":"2006","journal-title":"J. Rehabil. Res. Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/307465a0","article-title":"Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?","volume":"307","author":"DeCoursey","year":"1984","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0035-3787(04)71001-2","article-title":"[Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].","volume":"160","author":"Devaux","year":"2004","journal-title":"Rev. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/glia.23457","article-title":"The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo.","volume":"66","author":"Di Lucente","year":"2018","journal-title":"Glia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxicon.2018.07.014","article-title":"The Kv1.3 channel-inhibitory toxin BF9 also displays anticoagulant activity via inhibition of factor XIa.","volume":"152","author":"Ding","year":"2018","journal-title":"Toxicon"},{"key":"B29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/mol.64.1.59","article-title":"APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-go-related gene potassium channels.","volume":"64","author":"Diochot","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1074\/jbc.273.12.6744","article-title":"Sea anemone peptides with a specific blocking activity against the fast inactivating potassium channel Kv3.4.","volume":"273","author":"Diochot","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1006\/bbrc.1995.2214","article-title":"Chemical synthesis, structural and functional characterisation of noxiustoxin, a powerful blocker of lymphocyte voltage-dependent K+ channels.","volume":"213","author":"Drakopoulou","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/glia.23006","article-title":"Microglia-neuron communication in epilepsy.","volume":"65","author":"Eyo","year":"2017","journal-title":"Glia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity.","volume":"33","author":"Feske","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1523\/jneurosci.1251-05.2005","article-title":"Microglia Kv1.3 channels contribute to their ability to kill neurons.","volume":"25","author":"Fordyce","year":"2005","journal-title":"J. Neurosci."},{"key":"B35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1099-1387(199707)3:4<314::AID-PSC117>3.0.CO;2-E","article-title":"3D structure of kaliotoxin: is residue 34 a key for channel selectivity?","volume":"3","author":"Gairi","year":"1997","journal-title":"J. Pept. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1021\/bi970253d","article-title":"A new potassium channel toxin from the sea anemone Heteractis magnifica: isolation, cDNA cloning, and functional expression.","volume":"36","author":"Gendeh","year":"1997","journal-title":"Biochemistry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1073\/pnas.85.10.3329","article-title":"Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels.","volume":"85","author":"Gimenez-Gallego","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/19336950.2019.1635864","article-title":"Kv1.1 channel subunits in the control of neurocardiac function.","volume":"13","author":"Glasscock","year":"2019","journal-title":"Channels"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/bi300060n","article-title":"Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.","volume":"51","author":"Gurrola","year":"2012","journal-title":"Biochemistry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"19058","DOI":"10.1074\/jbc.M802054200","article-title":"Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease.","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cells7040026","article-title":"Microglia after seizures and in epilepsy.","volume":"7","author":"Hiragi","year":"2018","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10126-005-5093-2","article-title":"Peptide toxins in sea anemones: structural and functional aspects.","volume":"8","author":"Honma","year":"2006","journal-title":"Mar. Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.4049\/jimmunol.179.7.4563","article-title":"Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.","volume":"179","author":"Hu","year":"2007","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-017-0158-2","article-title":"Kv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis.","volume":"7","author":"Huang","year":"2017","journal-title":"Cell Biosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: from mechanisms to translation.","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12547","DOI":"10.1074\/jbc.M114.561324","article-title":"Nuclear localization and functional characteristics of voltage-gated potassium channel Kv1.3.","volume":"290","author":"Jang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1179\/016164106x98143","article-title":"Impact of IVIg on the interaction between activated T cells and microglia.","volume":"28","author":"Janke","year":"2006","journal-title":"Neurol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/14728222.6.6.623","article-title":"The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.","volume":"6","author":"Jensen","year":"2002","journal-title":"Expert Opin. Ther. Targets"},{"key":"B50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.5604\/01.3001.0010.3836","article-title":"Multiple sclerosis - etiology and diagnostic potential.","volume":"71","author":"Kaminska","year":"2017","journal-title":"Postepy Hig. Med. Dosw."},{"key":"B51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12576-014-0331-x","article-title":"Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.","volume":"65","author":"Kazama","year":"2015","journal-title":"J. Physiol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s0014-5793(97)00285-8","article-title":"Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels.","volume":"406","author":"Kharrat","year":"1997","journal-title":"FEBS Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics.","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.1434","article-title":"Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination.","volume":"201","author":"Kirk","year":"2003","journal-title":"J. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.toxicon.2015.04.018","article-title":"Solid phase synthesis, NMR structure determination of alpha-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.","volume":"101","author":"Kohl","year":"2015","journal-title":"Toxicon"},{"key":"B57","doi-asserted-by":"publisher","first-page":"10680","DOI":"10.1523\/jneurosci.19-24-10680.1999","article-title":"A Kv1.5 to Kv1.3 switch in endogenous hippocampal microglia and a role in proliferation.","volume":"19","author":"Kotecha","year":"1999","journal-title":"J. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/732806","article-title":"Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer\u2019s disease.","volume":"2010","author":"Krause","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020185","article-title":"Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos.","volume":"17","author":"Kristensen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/srep11322","article-title":"Swedish mutant APP-based BACE1 binding site peptide reduces APP beta-cleavage and cerebral Abeta levels in Alzheimer\u2019s mice.","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.drudis.2018.08.011","article-title":"Cnidarian peptide neurotoxins: a new source of various ion channel modulators or blockers against central nervous systems disease.","volume":"24","author":"Liao","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B62","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s1474-4422(11)70066-7","article-title":"Stroke and the immune system: from pathophysiology to new therapeutic strategies.","volume":"10","author":"Macrez","year":"2011","journal-title":"Lancet Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1460-9568.1997.tb01408.x","article-title":"Diversity of potassium channels contributing to differences in brain area-specific seizure susceptibility: sensitivity of different potassium channels to the epileptogenic agent pentylenetetrazol.","volume":"9","author":"Madeja","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/md17060325","article-title":"Sea anemone toxins: a structural overview.","volume":"17","author":"Madio","year":"2019","journal-title":"Mar Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/brain\/awx346","article-title":"Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer\u2019s disease: preclinical proof of concept.","volume":"141","author":"Maezawa","year":"2018","journal-title":"Brain"},{"key":"B66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases.","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy.","volume":"264","author":"Manford","year":"2017","journal-title":"J. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","article-title":"Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block.","volume":"29","author":"Matheu","year":"2008","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1074\/jbc.M115.680611","article-title":"Scorpion potassium channel-blocking defensin highlights a functional link with neurotoxin.","volume":"291","author":"Meng","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"13698","DOI":"10.1021\/bi035209e","article-title":"Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile.","volume":"42","author":"Middleton","year":"2003","journal-title":"Biochemistry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0014-5793(98)00403-7","article-title":"Primary structure of a potassium channel toxin from the sea anemone Actinia equina.","volume":"427","author":"Minagawa","year":"1998","journal-title":"FEBS Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom.","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines.","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1007\/s00018-008-8059-5","article-title":"Astrocytes in multiple sclerosis: a product of their environment.","volume":"65","author":"Nair","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4049\/jimmunol.179.1.346","article-title":"Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.","volume":"179","author":"Nicolaou","year":"2007","journal-title":"J. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0041-0101(91)90205-6","article-title":"Structure and structure-function relationships of sea anemone proteins that interact with the sodium channel.","volume":"29","author":"Norton","year":"1991","journal-title":"Toxicon"},{"key":"B77","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.07.002","article-title":"Venom-derived peptide inhibitors of voltage-gated potassium channels.","volume":"127","author":"Norton","year":"2017","journal-title":"Neuropharmacology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis.","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch. Med. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.09.013","article-title":"Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.","author":"Peelen","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/cge.12542","article-title":"Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.","volume":"87","author":"Pena","year":"2015","journal-title":"Clin. Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/neuonc\/not221","article-title":"Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.","volume":"16","author":"Peng","year":"2014","journal-title":"Neuro Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1006\/bbrc.1996.0297","article-title":"Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain.","volume":"219","author":"Pennington","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3181\/0705-rm-148","article-title":"Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.","volume":"232","author":"Pereira","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1517\/14728222.2016.1112792","article-title":"The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies.","volume":"20","author":"Perez-Verdaguer","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"B86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/bbrc.2000.3756","article-title":"Blockage of human T lymphocyte Kv1.3 channels by Pi1, a novel class of scorpion toxin.","volume":"278","author":"P\u00e9ter","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1110\/ps.073122908","article-title":"Chemical synthesis and 1H-NMR 3D structure determination of AgTx2-MTX chimera, a new potential blocker for Kv1.2 channel, derived from MTX and AgTx2 scorpion toxins.","volume":"17","author":"Pimentel","year":"2008","journal-title":"Protein Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nbd.2009.10.012","article-title":"Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer\u2019s disease.","volume":"37","author":"Poulopoulou","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10010036","article-title":"Sea anemones: quiet achievers in the field of peptide toxins.","volume":"10","author":"Prentis","year":"2018","journal-title":"Toxins"},{"key":"B90","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/imm.12559","article-title":"Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.","volume":"147","author":"Pucca","year":"2016","journal-title":"Immunology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/14728220903018957","article-title":"Kv1.3 potassium channels as a therapeutic target in multiple sclerosis.","volume":"13","author":"Rangaraju","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease.","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B93","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/jad-141704","article-title":"Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer\u2019s disease.","volume":"44","author":"Rangaraju","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/srep04509","article-title":"A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases.","volume":"4","author":"Rashid","year":"2014","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/(sici)1097-0134(20000101)38:1<70::aid-prot8>3.0.co;2-5","article-title":"Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus martensi.","volume":"38","author":"Renisio","year":"2000","journal-title":"Proteins"},{"key":"B96","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/08916930600739605","article-title":"The complement system in central nervous system diseases.","volume":"39","author":"Rus","year":"2006","journal-title":"Autoimmunity"},{"key":"B97","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1073\/pnas.0501770102","article-title":"The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.","volume":"102","author":"Rus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1469.e12","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease.","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.02.008","article-title":"The relation between alpha-synuclein and microglia in Parkinson\u2019s disease: recent developments.","volume":"302","author":"Sanchez-Guajardo","year":"2015","journal-title":"Neuroscience"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/jnc.13891","article-title":"Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.","volume":"140","author":"Schwartz","year":"2017","journal-title":"J. Neurochem."},{"key":"B102","doi-asserted-by":"publisher","first-page":"25121","DOI":"10.1074\/jbc.270.42.25121","article-title":"Kalicludines and kaliseptine. Two different classes of sea anemone toxins for voltage sensitive K+ channels.","volume":"270","author":"Schweitz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years.","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1523\/jneurosci.06-06-01570.1986","article-title":"Noxiustoxin, a short-chain toxin from the Mexican scorpion Centruroides noxius, induces transmitter release by blocking K+ permeability.","volume":"6","author":"Sitges","year":"1986","journal-title":"J. Neurosci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.neurobiolaging.2008.07.021","article-title":"Co-occurrence of Alzheimer\u2019s disease ss-amyloid and tau pathologies at synapses.","volume":"31","author":"Takahashi","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","article-title":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.","volume":"180","author":"Tanner","year":"2017","journal-title":"Clin. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180762","article-title":"Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial.","volume":"12","author":"Tarcha","year":"2017","journal-title":"PLoS One"},{"key":"B109","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.yexmp.2011.04.006","article-title":"C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation.","volume":"91","author":"Tegla","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.imlet.2010.06.009","article-title":"Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.","volume":"133","author":"Toldi","year":"2010","journal-title":"Immunol. Lett."},{"key":"B111","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.137.2.459","article-title":"Differentiation and death of premyelinating oligodendrocytes in developing rodent brain.","volume":"137","author":"Trapp","year":"1997","journal-title":"J. Cell Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.celrep.2016.08.016","article-title":"Decrease of a current mediated by Kv1.3 channels causes striatal cholinergic interneuron hyperexcitability in experimental parkinsonism.","volume":"16","author":"Tubert","year":"2016","journal-title":"Cell Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/wnl.0000000000003092","article-title":"Role of atherosclerosis, clot extent, and penumbra volume in headache during ischemic stroke.","volume":"87","author":"van Os","year":"2016","journal-title":"Neurology"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106373","article-title":"Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.","author":"Verdura","year":"2019","journal-title":"J. Med. Genet."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0257-7","article-title":"Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4(+) effector memory T cell response to TCR stimulation.","volume":"16","author":"Veytia-Bucheli","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"B116","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1586\/17434440.2016.1143772","article-title":"Evolution of endovascular stroke therapies and devices.","volume":"13","author":"Wallace","year":"2016","journal-title":"Expert Rev. Med. Devices"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/s0028-3908(02)00237-x","article-title":"Potassium channels as anti-epileptic drug targets.","volume":"43","author":"Wickenden","year":"2002","journal-title":"Neuropharmacology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0306-4522(01)00446-8","article-title":"Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus.","volume":"108","author":"Wittner","year":"2001","journal-title":"Neuroscience"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/srep29431","article-title":"Mapping the interaction anatomy of BmP02 on Kv1.3 Channel.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/jci16921","article-title":"The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.","volume":"111","author":"Wulff","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B121","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets.","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B122","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41573-019-0013-8","article-title":"Antibodies and venom peptides: new modalities for ion channels.","volume":"18","author":"Wulff","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1021\/cr078234p","article-title":"K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.","volume":"108","author":"Wulff","year":"2008","journal-title":"Chem. Rev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jbt.21538","article-title":"BF9, the first functionally characterized snake toxin peptide with Kunitz-type protease and potassium channel inhibiting properties.","volume":"28","author":"Yang","year":"2014","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease.","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/toxins7051749","article-title":"Toxins targeting the Kv1.3 channel: potential immunomodulators for autoimmune diseases.","volume":"7","author":"Zhao","year":"2015","journal-title":"Toxins"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05675.x","article-title":"The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production.","volume":"107","author":"Zheng","year":"2008","journal-title":"J. Neurochem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2018.07.009","article-title":"Alleviating airway inflammation by inhibiting ERK-NF-kappaB signaling pathway by blocking Kv1.3 channels.","volume":"63","author":"Zhou","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.toxicon.2011.11.016","article-title":"Two dyad-free Shaker-type K(+) channel blockers from scorpion venom.","volume":"59","author":"Zhu","year":"2012","journal-title":"Toxicon"}],"updated-by":[{"DOI":"10.3389\/fnins.2020.00163","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000}}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T23:39:52Z","timestamp":1582933192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":129,"alternative-id":["10.3389\/fnins.2019.01393"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.01393","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fnins.2020.00163","asserted-by":"object"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"article-number":"1393"}}